In severe cases, a viral hepatitis infection can result in liver failure. A research n.team has now discovered how this occurs: by immune cells attacking cells in the vascular system, which disrupts the organ's blood and nutrient supply. This is responsible for the overwhelming damage that causes the liver to fail. Using an animal model, the researchers were then able to identify an agent to prevent this lethal process.
An infection of the liver with viral hepatitis, such as the hepatitis B virus, can progress in very different ways: the liver inflammation (hepatitis) can heal again without any problems; become chronic and require lifelong medication; or take a fulminant - i.e. potentially fatal - course. In the latter case, the immune-mediated damage to the liver is so severe that the organ fails, leaving a liver transplant as the last remaining treatment option.
Hepatitis viruses target the liver cells, or hepatocytes. The immune system tries to bring the infection under control by attacking and destroying the infected liver cells with the help of certain immune cells, known as killer T-cells. It was previously assumed that this process was also responsible for the severe organ damage that accompanies acute hepatitis. Now, researchers have arrived at a completely different explanation. They discovered that this organ failure is not in fact caused by the death of liver cells, but by defects in the vascular (blood vessel) system.
The liver is home to important cells called liver sinusoidal endothelial cells, or LSECs for short. These connect the cells of the liver to the vascular system and regulate the exchange of nutrients and oxygen with the blood. They also have the ability to present small fragments of viruses on their outer membrane, in a similar way to immune system cells. The researchers observed that the killer T-cells specifically detected these viral particles, mistaking the LSECs for infected liver cells and destroying them. To this end, they used proteins that integrate into the cell membrane of the target cell and form a pore. Known as perforins, these proteins perforate the membrane and destroy the cell.
"We observed that the elimination of LSECs by the immune cells has an enormous impact on the liver tissue. Blood flow within the liver is hugely disrupted, with large numbers of liver cells - even those not infected - dying as a result. This immune response has a much more dramatic effect than the attack on liver cells that are actually infected," the researcher explains. This discovery was made possible by a new mouse model specially developed by the researchers to replicate the fulminant course of viral hepatitis.
"Only now that we have pinpointed the actual destructive mechanism in acute hepatitis can we consider new treatment strategies and specifically target this process," underscores another author. Using their mouse model, the researchers were able to show that a new active substance can prevent fulminant hepatitis. This is a perforin inhibitor, which stops the killer T-cells from forming pores and thus safeguards the LSECs from attack. This agent successfully protected the mice from developing fulminant hepatitis, since the LSECs remained intact, preserving the blood supply to the liver cells.
https://www.tum.de/nc/en/about-tum/news/press-releases/detail/article/35148/
https://www.nature.com/articles/s41467-018-07213-x
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fperforin-inhibition&filter=22
Latest News
A novel therapy using unique thermogel prevents retinal scarring
A new live-attenuated influenza A vaccine
Sex differences in the alcohol mediated brain activity
The mere sight of a meal triggers an inflammatory response in the brain
Some viruses make you smell tastier to mosquitoes
Other Top Stories
Targeting RNA with small molecules to treat hand, foot and mouth disease
HIV drugs could prevent diabetes
Highly effective antibodies against the coronavirus were identified
Impaired type I interferon signaling may contribute to severe COVID-19 symptoms
CRISPR-based malaria test
Protocols
Generation of precision-cut slice cultures of human placenta
Light and electron microscopic imaging of synaptic vesicle endocytosis at mouse hippocampal cultures
FLAMBE: A kinetic fluorescence polarization assay to study activation of monomeric BAX
Single-cell mass spectrometry
A behavioral paradigm for measuring perceptual distances in mice
Publications
A bio-functional polymer that prevents retinal scarring through modulation of NRF2 signalling pat…
Magnetoencephalography with optically pumped magnetometers (OPM-MEG): the next generation of func…
Generation of a live attenuated influenza A vaccine by proteolysis targeting
Neat1 promotes acute kidney injury to chronic kidney disease by facilitating tubular epithelial c…
Sex differences in the alcohol-mediated modulation of BLA network states
Presentations
Hydrogels in Drug Delivery
Lipids
Cell biology of carbohydrate metabolism
RNA interference (RNAi)
RNA structure and functions
Posters
ASCO-2020-HEALTH SERVICES RESEARCH AND QUALITY IMPROVEMENT
ASCO-2020-HEAD AND NECK CANCER
ASCO-2020-GENITOURINARY CANCER–KIDNEY AND BLADDER
ASCO-2020-GENITOURINARY CANCER–PROSTATE, TESTICULAR, AND PENILE
ASCO-2020-GYNECOLOGIC CANCER